Related references
Note: Only part of the references are listed.Molecular Structure of Heparan Sulfate from Spalax IMPLICATIONS OF HEPARANASE AND HYPOXIA
Elina Sandwall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Cerebral amyloid angiopathy and its relationship to Alzheimer's disease
Dietmar Rudolf Thal et al.
ACTA NEUROPATHOLOGICA (2008)
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Dennis J. Selkoe
BEHAVIOURAL BRAIN RESEARCH (2008)
Oligomer-specific Aβ toxicity in cell models is mediated by selective uptake
Sidhartha M. Chafekar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
The ratio of monomeric to aggregated forms of Aβ40 and Aβ42 is an important determinant of amyloid-β aggregation, fibrillogenesis, and toxicity
Asad Jan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate
Martha L. Escobar Galvis et al.
NATURE CHEMICAL BIOLOGY (2007)
Heparan sulphate proteoglycans fine-tune mammalian physiology
Joseph R. Bishop et al.
NATURE (2007)
A beta Oligomers - a decade of discovery
Dominic M. Walsh et al.
JOURNAL OF NEUROCHEMISTRY (2007)
FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium
S. Donnini et al.
CELL DEATH AND DIFFERENTIATION (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
The beta-amyloid peptide of Alzheimer's disease decreases adhesion of vascular smooth muscle cells to the basement membrane
SS Mok et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Immunotherapy of Alzheimer's disease (AD): From murine models to anti-amyloid beta (A beta) human monoclonal antibodies
V Geylis et al.
AUTOIMMUNITY REVIEWS (2006)
The role of heparan sulphate in inflammation
Christopher R. Parish
NATURE REVIEWS IMMUNOLOGY (2006)
Adaptive evolution of heparanase in hypoxia-tolerant Spalax:: Gene cloning and identification of a unique splice variant
NJ Nasser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis
JP Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers
A Demuro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
PrPSc incorporation to cells requires endogenous glycosaminoglycan expression
N Hijazi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Natural oligomers of the amyloid-protein specifically disrupt cognitive function
JP Cleary et al.
NATURE NEUROSCIENCE (2005)
Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and β-amyloid accumulation in a mouse model of Alzheimer's disease
L Bergamaschini et al.
JOURNAL OF NEUROSCIENCE (2004)
A modified β-amyloid hypothesis:: intraneuronal accumulation of the β-amyloid peptide -: the first step of a fatal cascade
O Wirths et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Heparan sulfate structure in mice with genetically modified heparan sulfate production
J Ledin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Alzheimer's disease-affected brain:: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
YS Gong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders
J van Horssen et al.
LANCET NEUROLOGY (2003)
Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-β in vitro
L Bergamaschini et al.
NEUROBIOLOGY OF AGING (2002)
Intraneuronal A beta 42 accumulation in human brain
GK Gouras et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
